ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 93868 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 93868; 2) Community: the network communities that were significantly associated with the response to NSC 93868; 3) Molecule: the relationships between components within communities and NSC 93868; 4) MDR: the compounds that were significantly associated with the NSC 93868.

NSC Compound Enrichment Correlation
NSC 684459 7H-Pyrido[3,2-d][1]benzazepine-6-thione, 4-(4-bromo- phenyl)-5,6-dihydro-2-phenyl- 0.0309214021749425 -0.11316515
NSC 696254 Null 0.0309214021749425 -0.12450639
NSC 734294 Indenoisoquinoline derivative 0.0309214021749425 0.14835639
NSC 757949 (1R,2E,6R,10E,11aS,13S,14aR)-6-(2-(benzyloxy)ethyl)-1,13-dihydroxy-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one 0.0309214021749425 0.11187304
NSC 645807 ANTINEOPLASTIC-645807 0.0354217693930257 0.068454079
NSC 679528 Null 0.0354217693930257 -0.23126964
NSC 105014 Cladribine 0.0395466756030208 -0.083191205
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0395466756030208 -0.023596321
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0395466756030208 0.068309352
NSC 163443 Null 0.0395466756030208 -0.23941811
Total:28  Current:20    [First] [Prev] [Next] [Last]